August 17, 2022
Article
Sean Dickson of West Health Policy Center discusses Reuters' analysis of drug launch prices.
August 11, 2022
Article
The EUA allows Jynneos to be used in children at high risk for monkeypox and as an intradermal injection, rather than subcutaneous, for adults.
August 10, 2022
Article
A rise in the number of long COVID is sparking research efforts by the HHS, the CDC and drug companies to understand the conditions and develop treatments.
August 03, 2022
Article
OptumRx profiles four therapies that are expecting FDA decisions in the next few months.
July 28, 2022
Article
The bipartisan bill introduced in the Senate in May would require PBMs to report to the FTC how much money they make through spread pricing and pharmacy fees.
July 26, 2022
Article
Next year, seven biosimilars of Humira are expected to launch, but leaders from the Biosimilars Forum are concerned not all will make it onto formularies.